Patents
Literature
Patsnap Eureka AI that helps you search prior art, draft patents, and assess FTO risks, powered by patent and scientific literature data.

163results about How to "No obvious side effects" patented technology

Targeted BRD7 tumor suppressor protein stabilizing agent and application thereof in preparation of solid tumor treatment drugs

The invention belongs to the field of tumor treatment medicines, and particularly relates to a stabilizing agent aiming at BRD7 tumor suppressor protein, which is a free compound with a structure # imgabs0 # as shown in a formula 1, pharmaceutically acceptable salt, crystal and solvate. The invention also comprises application of the stabilizing agent of the targeted BRD7 tumor suppressor protein in preparation of drugs for treating solid tumors. Researches show that the compound in the formula 1 has an effect of stabilizing BRD7 protein, and can realize efficient inhibition on solid tumors such as breast cancer, nasopharynx cancer and lung cancer based on a mechanism of stabilizing BRD7 tumor suppressor protein.
Owner:CENT SOUTH UNIV

New application of moss phenol glucoside

The invention belongs to the technical field of medicines, and particularly discloses application of moss phenol glucoside in preparation of medicines for preventing and / or treating tumors. According to the method, activated CD8 + T cells, MC38-OVA cells and traditional Chinese medicine monomeric compounds are co-cultured, the traditional Chinese medicine monomeric compounds capable of effectively promoting the anti-tumor activity of the CD8 + T cells are selected by utilizing a high-content screening technology, and finally, the experiment is carried out by taking the moss phenol glucoside as a research object. In-vitro experiment results show that the moss phenol glucoside can significantly promote T cell activation, promote release of cell factors such as IFN-gamma and TNF-alpha, and enhance the killing effect of T cells on tumors. A mouse in-vivo tumor-bearing experiment result shows that the moss phenol glucoside can promote the anti-tumor activity of T cells so as to inhibit tumor growth, has no obvious toxic or side effect, can be used for preparing the medicine for preventing and / or treating tumors, and has a potential clinical application prospect and a relatively high economic value.
Owner:ZHENGZHOU UNIV

Application of multi-target polypeptide in preparation of medicine for treating organ fibrosis

The invention relates to application of a multi-target polypeptide in preparation of a medicine for treating organ fibrosis, in particular to application of a polypeptide mini-klotho and a gene therapy vector and method thereof in preparation of medicines for treating fibrosis of kidney, liver, lung and other organs. The invention provides the application of mini-klotho in a model for treating kidney, liver and lung fibrosis, and the mini-klotho has a remarkable curative effect and does not have obvious toxic or side effects. Therefore, the mini-klotho disclosed by the invention can be prepared into a medicinal preparation for treating the organ fibrosis.
Owner:NANFANG HOSPITAL OF SOUTHERN MEDICAL UNIV

Application of sclareol in preparation of medicine for resisting porcine reproductive and respiratory syndrome virus

The invention discloses application of sclareol in preparation of drugs for resisting porcine reproductive and respiratory syndrome virus, and belongs to the field of veterinary drugs. According to the invention, Marc-145 cells are taken as host cells, a plurality of porcine reproductive and respiratory syndrome virus strains are selected for infection, and the antiviral performance of sclareol is tested; experimental results show that 30-50 [mu] M sclareol has no obvious toxicity to host cells, and can significantly inhibit infection of different porcine reproductive and respiratory syndrome virus strains in the host cells. The sclareol has good activity of resisting porcine reproductive and respiratory syndrome virus infection, and the sclareol is a medicine with a natural source, has the advantages of safety, few side effects, low metabolic residue and no pollution, and provides a reliable basis for treatment, prevention and control of porcine reproductive and respiratory syndrome.
Owner:HUAZHONG AGRI UNIV

Calculus bovis Angong reconstituted soft capsule and production process thereof

The invention discloses a bezoar Angong reconstituted soft capsule and a production process, and relates to the field of fish culture. The calculus bovis Angong reconstituted soft capsule comprises a ginkgo biloba extract, hirudin, L-borneol, a schisandra chinensis extract, a hypericin extract, ginsenoside, calculus bovis, resveratrol, chromium-enriched yeast, a ligusticum wallichii extract, licorzinc, rheum officinale, selenium, metformin, NMN (nicotinamide mononucleotide) and coenzyme Q10. The production process of the calculus bovis Angong reconstituted soft capsule comprises five steps of material preparation, supercritical fluid extraction, concentration and purification, drug microencapsulation and soft capsule preparation. The calculus bovis Angong reconstituted soft capsule has remarkable advantages in the aspects of reducing liver function indexes, improving blood sugar and blood fat and protecting heart and liver tissues, and the extraction efficiency, stability and bioavailability of the calculus bovis Angong reconstituted soft capsule can be remarkably improved by optimizing a supercritical fluid extraction process and introducing a microencapsulation technology.
Owner:HEILONGJIANG RUZHONG MEDICAL TECH CO LTD

Application of asperuloside in preparation of medicine for treating diabetic nephropathy

The invention provides application of asperuloside in preparation of a medicine for treating diabetic nephropathy, the structural formula of the asperuloside is as shown in the specification, and imgabs0 #. Experiments find that the asperuloside has the effect of delaying the diabetic nephropathy of db / db mice, and a new method is provided for treating the diabetic nephropathy.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

Preparation method of 4-isopropenylphenol

The invention discloses a preparation method of 4-isopropenylphenol, which comprises the following steps: firstly, carrying out reaction on p-hydroxyacetophenone and 3, 4-dihydropyran to generate 1-(4-tetrahydropyran-2-oxyphenyl) ethanone; the preparation method comprises the following steps: firstly, reacting methyltriphenylphosphonium bromide with potassium tert-butoxide to prepare a phosphorus ylide reagent, and then reacting 1-(4-tetrahydropyran-2-oxyphenyl) ethanone with the phosphorus ylide reagent to generate 2-(4-(1-propylene-2-yl) phenoxyl) tetrahydro-2H-pyran; finally, the 2-(4-(1-propylene-2-yl) phenoxy) tetrahydro-2H-pyran is subjected to deprotection, and the 4-isopropenyl phenol is obtained. According to the preparation method disclosed by the invention, each step of reaction is relatively clean, no obvious side reaction exists, the process pollution is small, each step of reaction condition is mild, the operation is simple and safe, the post-treatment flow is simple, the raw materials are simple and easy to obtain, the cost is low, the industrial production is easy, and the yield and the purity of the target product 4-isopropenylphenol are relatively high.
Owner:XIAN EDKEMEI NEW MATERIAL CO LTD

Application of triptophenolide in preparation of medicine for treating diabetic nephropathy

The invention provides application of triptophenolide in preparation of a medicine for treating diabetic nephropathy, the structural formula of the triptophenolide is as shown in the specification, and # imgabs0 #. Experiments find that the triptophenolide has the effect of delaying the diabetic nephropathy of db / db mice, and a new method is provided for treating the diabetic nephropathy.
Owner:THE FIRST MEDICAL CENT CHINESE PLA GENERAL HOSPITAL

MRNA (messenger ribonucleic acid) and mRNA lipid nanoparticle compound for preventing and treating triple negative breast cancer as well as preparation method and application of mRNA lipid nanoparticle compound

The embodiment of the invention belongs to the technical field of biological medicines, and particularly relates to mRNA and mRNA lipid nanoparticle compounds for preventing and treating triple negative breast cancer as well as a preparation method and application of the mRNA and mRNA lipid nanoparticle compounds. The mRNA comprises a coding region of alpha-whey protein. The mRNA lipid nanoparticle compound comprises a nanoparticle lipid shell and the mRNA, the mRNA is encapsulated in the lipid shell, and a coding region of the alpha-whey protein has a nucleotide sequence as shown in SEQ ID NO. 6. According to the alpha-whey protein mRNA provided by the invention, mRNA for preventing and treating triple negative breast cancer is delivered to a body through a lipid nanoparticle delivery system, so that alpha-whey protein is transiently expressed, cellular response and humoral immunity of the body are activated, infiltration of CD8 positive T cells is promoted, a specific antibody is formed, and the effect of preventing or killing tumor cells is achieved; no obvious toxic or side effect exists.
Owner:THE SEVENTH AFFILIATED HOSPITAL SUN YAT SEN UNIV SHENZHEN

Maternal peptide or derivative peptide with CCR7 affinity effect and application thereof

The invention discloses a parent peptide or a derivative peptide with a CCR7 affinity effect and application of the parent peptide or the derivative peptide. The CCR7 protein affinity peptide is shown as any one of the following items: A1) a polypeptide with an amino acid sequence of L-S-P-L-I-F-V-T-T-P-D-T; a2) a derivative polypeptide obtained by carrying out 1-3 mutations on the second-site to twelfth-site amino acid residues in the polypeptide as shown in A1); a3), a tag is connected to the N end and / or the C end of the polypeptide such as A1) or A2) to obtain the fusion polypeptide. It is found that the CCR7 protein affinity peptide has a good affinity blocking effect on CCR7-CC21 / CC19 protein interaction, can inhibit ERK1 / 2 phosphorylation and lymph node metastasis, and can provide a new effective treatment strategy and candidate molecules for improving the anti-tumor effect.
Owner:SUN YAT SEN UNIV

Application of ventral hippocampal region transferrin receptor 1 inhibitor in preparation of drug for preventing and / or treating anxiety disorder

PendingCN119280406AImprove anxiety symptomsDoes not affect cognitionNervous disorderAnhydride/acid/halide active ingredientsHippocampal regionAnimal brain
The invention relates to application of a ventral hippocampal region transferrin receptor 1 inhibitor in preparation of a medicine for preventing and / or treating anxiety disorder, and belongs to the technical field of biological medicine. The application of the inhibitor for interfering with the animal brain ventral hippocampal region transferrin receptor 1 (TfR1) in the drugs for preventing and / or treating anxiety is discovered and proposed for the first time. Animal experiments prove that anxiety disorder caused by social isolation stress is closely related to TfR1 in a brain abdominal side hippocampus area of an animal, and when the animal shows anxiety symptom, the expression level of TfR1 is improved, so that the iron concentration in the brain abdominal side hippocampus area is improved to cause iron disorder. On the basis of the research, an inhibitor for interfering with the TfR1 in the belly hippocampus area of the brain of the animal is injected into an anxiety model animal, social isolation treatment is continued, the anxiety behavior of the animal in a social isolation treatment group is improved, and the effect of treating the anxiety is achieved.
Owner:SOUTH CHINA UNIV OF TECH

A traditional Chinese medicine extract with antibacterial, anti-inflammatory and antipyretic effects, and an active ingredient self-assembled nanomaterial and application thereof

The application discloses a traditional Chinese medicine extract with antibacterial, anti-inflammatory and antipyretic effects and an active component self-assembled nanomaterial of the traditional Chinese medicine extract and application, wherein the polygonum capitatum extract and the active component self-assembled nanomaterial have the effects of inhibiting bacteria and relieving inflammation and can be used for treating atopic dermatitis. The in-vitro bacteriostatic experiment and animal experiment results verify that the polygonum capitatum extract and the active component self-assembled nanomaterial have the effects of resisting bacteria and inflammation and can effectively treat atopic dermatitis.
Owner:CHINA PHARM UNIV

A traditional Chinese medicine composition, its usage, preparation method and application

This invention relates to the field of traditional Chinese medicine composition technology, and particularly to a method of using, preparing, and applying a traditional Chinese medicine composition. The traditional Chinese medicine composition is prepared from raw materials comprising a first component, a second component, a third component, and a fourth component: the first component comprises a mixture of raw oyster shell, prunella vulgaris, and fritillaria thunbergii; the second component comprises a mixture of angelica sinensis, scorpion, notoginseng, and cattail pollen; the third component comprises one or more of lindera strychnifolia, chuanxiong rhizome, cyperus rotundus, and corydalis yanhusuo; the fourth component comprises one or more of fenugreek, angelica dahurica, and fennel; the mass ratio of the first component to the second component is 1.3–2:1. This traditional Chinese medicine composition can not only significantly prevent and alleviate dysmenorrhea symptoms in patients with acute menstrual cramps (AM), but also improve other accompanying symptoms during menstruation in AM patients, such as heavy menstrual bleeding.
Owner:DONGFANG HOSPITAL BEIJING UNIV OF CHINESE MEDICINE

Application of solanesol in preparation of medicine for repairing oral ulcer

The invention relates to the technical field of oral medicine, in particular to application of solanesol in preparation of a medicine for promoting dental ulcer repair. Based on an established mouse oral ulcer model, solanesol is used as a PI 3K-Akt signal channel regulator, a TRP signal channel regulator, a TNF signal channel regulator and a p53 signal channel regulator, and a series of cell application concentration experiments are carried out. The technical scheme that solanesol with a specific concentration is used as the medicine component for promoting dental ulcer repair is determined, the characteristics of good curative effect and high safety are achieved, the operation is convenient in practical application, and the patient compliance during dental ulcer treatment is improved.
Owner:PEKING UNIV SCHOOL OF STOMATOLOGY

Vagina flora repairing liquid and preparation method thereof

The invention provides a vaginal flora repairing liquid and a preparation method thereof. Specifically, the repair liquid prepared from the lactobacillus paracasei CGMCC No. 1.12731, the lactobacillus rhamnosus CGMCC 24282 and the lactobacillus gasseri CGMCC No. 22909 in a specific mass ratio can be used for well killing pathogenic bacteria, has no obvious toxic or side effect and is low in cost. The broad-spectrum vaginitis bactericidal peptide YDG-C screened by the invention is further added into the repair liquid, so that the treatment effect on bacterial vaginitis can be further improved. The preparation method is simple, low in cost and suitable for large-scale popularization and application.
Owner:BEIJING WANGJIANG BIOTECHNOLOGY CO LTD

A compound preparation for treating vascular dementia and a preparation method thereof

This invention discloses a compound preparation for treating vascular dementia and its preparation method. The active pharmaceutical ingredient consists of protopanaxadiol and gallic acid in a 1:1 mass ratio, and the dosage form is liposomes. The preparation method includes extraction, mixing, liposome preparation, and optional freeze-drying steps: protopanaxadiol and gallic acid are extracted and purified from ginseng rhizome and Terminalia chebula fruit, respectively. After mixing, they are combined with phospholipids and cholesterol to prepare a lipid membrane. The membrane is then homogenized by hydration, low-temperature ultrasound, and high-pressure microfluidic jet to obtain a homogeneous liposome suspension, which can be further freeze-dried into a freeze-dried powder. The 1:1 composition of protopanaxadiol and gallic acid targets multiple points on the pathological mechanism of vascular dementia, showing significant therapeutic effects and broad application prospects. This preparation uses a liposome dosage form to improve the bioavailability of the active ingredient, the preparation process parameters are controllable, the active ingredient has high purity, the liposomes have uniform particle size, high encapsulation efficiency, and good stability.
Owner:GUANGDONG HOSPITAL OF TRADITIONAL CHINESE MEDICINE

Formula for improving thrombus dissolving capacity of human body, preparation method and application thereof

The invention provides a composition for improving the thrombolysis capacity of a human body, a preparation method and application thereof.The composition is prepared from, by weight, 5-30 parts of earthworm protein, 30-120 parts of hippophae rhamnoides total flavone extract, 50-150 parts of silymarin extract, 20-80 parts of maltodextrin and 15-60 parts of pregelatinized starch, the earthworm protein activates a fibrinolytic system to promote t-PA to release and dissolve thrombus, and the hippophae rhamnoides total flavone extract activates the fibrinolytic system to promote t-PA to release and dissolve thrombus; the hippophae rhamnoides total flavonoids regulate the ratio of PGI2 / TXA2 to inhibit platelet aggregation and reduce blood fat, the silymarin protects the liver function to enhance LDL-C metabolism clearing, the hippophae rhamnoides total flavonoids, the silymarin and the hippophae rhamnoides total flavonoids cooperate to form a thrombolysis-antithrombosis-metabolism regulation three-dimensional intervention system, a whole-course low-temperature mixing direct tabletting process is adopted
Owner:NANJING DONGMA BIOTECHNOLOGY CO LTD

Compound with cerebral apoplexy treatment characteristic as well as preparation method and application thereof

The invention discloses a compound with a cerebral apoplexy treatment characteristic and a preparation method and application thereof. The compound is a compound formed by yeast peptide and hydroxytyrosol; the yeast peptide is generated by performing enzymolysis on yeast protein by papain, and the molecular mass of the yeast peptide is greater than or equal to 1kDa and less than 3kDa; when the papain is used for carrying out enzymolysis on the yeast protein, the pH value is 6.8-7.2, the enzymolysis time is 3.8-4.2 hours, the enzymolysis temperature is 48-52 DEG C, and the enzyme amount / mass ratio of the papain to the yeast protein in an enzymolysis system is 8800-9200U / g. The compound is used for preparing medicines for treating cerebral arterial thrombosis. The invention provides an efficient, safe and economical stroke treatment characteristic compound, and the compound has wide application prospects and remarkable technical advantages, and the preparation method is simple and low in cost.
Owner:BEIJING TECH & BUSINESS UNIV

Preparation method of traditional Chinese medicine combination for treating nephroptosis, pyelonephritis ascites and nephritis

PendingCN122321071Aeasy to useHigh cure rateNephroptosisRegimen
This invention provides a traditional Chinese medicine composition for treating renal edema, pyelonephritis with ascites, and nephritis. It consists of over 20 herbs including Atractylodes lancea, Areca catechu, Saposhnikovia divaricata, and Alisma plantago-aquatica (specific formulation details can be found in the original text). It can be prepared as pills, granules, or decoctions for oral administration. Core efficacy: 1. Promotes diuresis and reduces swelling, eliminating renal ascites; 2. Clears heat and detoxifies, anti-inflammatory and antibacterial (synergistic effect on fungal infections and cervical erosion); 3. Regulates renal function and improves abnormal uric acid metabolism. Treatment plan: Mild cases: Use five basic formulas (①-⑤) composed of Codonopsis pilosula, Poria cocos, etc., taken three times daily; Severe cases: Use a potent diuretic formula containing Akebia trifoliata and Euphorbia pekinensis (one spoonful of pills twice daily); Treatment course is approximately one month, with a follow-up examination after three months. Advantages: Cure rate reaches 90%, low recurrence rate – pure traditional Chinese medicine preparation, no significant toxic side effects; also treats complications (fungal infection, cervical lesions). This treatment plan has been clinically verified through three generations and has significant efficacy in treating renal edema, ascites, and nephritis.
Owner:李爱松

Internal heterosis prescription for dysmenorrhea caused by endometriosis

The invention relates to the technical field of medicine, and particularly discloses an endometriosis prescription for dysmenorrhea with endometriosis. Comprising the following raw materials: 10-15 parts of radix salviae miltiorrhizae, 7-10 parts of rhizoma curcumae, 2-3 parts of flos carthami, 7-10 parts of vinegar turtle shell, 10-15 parts of salted radix achyranthis bidentatae, 7-10 parts of rhizoma corydalis, 10-15 parts of prepared fingered citron, 5-8 parts of radix bupleuri, 10-15 parts of radix paeoniae alba, 10-15 parts of caulis spatholobi, 10-15 parts of poria cocos, 7-10 parts of herba taxilli, 7-10 parts of radix dipsaci, 3-5 parts of fructus amomi, 7-10 parts of endothelium corneum gigeriae galli, 10-15 parts of hawthorn and 7-10 parts of liquorice. The agreement prescription of the internal different prescription has obvious curative effects on improvement of dysmenorrhea symptoms of EMs patients, reduction of tentacle nodules and appendage masses, improvement of pelvic cavity states, increase of pregnancy rates and the like, and is safe and free of obvious toxic and side effects.
Owner:FOSHAN CHANCHENG CENT HOSPITAL CO LTD

Composition for promoting rapid growth of hair and application thereof

The invention relates to the field of A61K8 / 00, in particular to a composition for promoting rapid growth of hair and application of the composition. By adopting the specific amino acid composition, the physiological active component, the plant source glucoside, the protein hydrolysate, the diguanide tetraphosphate and the anti-inflammatory agent, through the synergistic effect of all the active raw materials, the provided composition for promoting rapid growth of hair is added to prepare hair washing and hair care products, and the hair washing and hair care products are applied to people with alopecia to use or treat the alopecia. Hair stem cell stimulation and rapid hair follicle regeneration are effectively induced, scalp aging is prevented, the treatment effect is remarkable, and no obvious side effect exists.
Owner:MINGXING KEPAI BIOTECHNOLOGY (SHANGHAI) CO LTD

Medicinal and edible formula for resisting cold and enhancing immunity

The invention discloses a medicinal and edible formula for resisting cold and enhancing immunity. The invention belongs to the technical field of medicine and food, according to the theory of traditional Chinese medicine, a plurality of medicine and food homologous raw materials with the effects of resisting cold and enhancing immunity are selected for scientific compatibility; the raw materials used in the traditional Chinese medicine composition cooperate with each other, so that the traditional Chinese medicine composition not only can effectively prevent cold, but also can relieve symptoms and promote physical rehabilitation during a cold period, and meanwhile, can improve organism immunity and enhance defense capability of organisms to various diseases after being taken for a long time; the health-care food adopts medicinal and edible raw materials, is high in safety, has no obvious toxic or side effect, is suitable for people of different ages to take for a long time, and is used as a functional food or health-care product for daily health care and cold prevention; the preparation method is simple and easy to implement, can be prepared into different oral dosage forms according to actual requirements, and is convenient to produce, store, transport and take.
Owner:BEIJING BAOFUTANG INST OF TRADITIONAL CHINESE MEDICINE

A Chinese medicine composition for treating Alzheimer's disease and its preparation method and application

The present invention provides a Chinese medicine composition for treating or preventing Alzheimer's disease, and its preparation method and application, wherein the Chinese medicine composition comprises the following raw materials in parts by mass: 10-20 parts of ginseng, 10-20 parts of polygala, 10-20 parts of calamus, 10-20 parts of tuckahoe, 10-20 parts of yam, 10-20 parts of polygonatum, 10-20 parts of green tea pigments and 10-20 parts of quercetin, and optionally comprises 0.1-0.5 parts of black pepper. The Chinese medicine composition of the present invention has a significant therapeutic effect on 5XFAD transgenic AD mice, which is specifically manifested in that daily oral administration of the Chinese medicine composition of the present invention improves the spatial learning and memory disorders of dementia mice, reduces the deposition of amyloid plaques in the dentate gyrus of the hippocampus of mice, and significantly inhibits the generation of Aβ without causing liver and kidney toxicity and weight loss. Therefore, the Chinese medicine composition of the present invention is a safe and effective method for treating AD.
Owner:THE UNIVERSITY OF HONG KONG

An antibacterial hydrogel made from traditional Chinese medicine for ulcer healing, its preparation method and application

This invention belongs to the field of traditional Chinese medicine technology, specifically relating to a herbal antibacterial hydrogel for ulcer healing, its preparation method, and its application. The hydrogel is composed of a herbal composition and a matrix. The herbal composition includes dandelion, angelica, scrophularia, forsythia, phellodendron, atractylodes, angelica dahurica, and raw licorice. The matrix contains chitosan, polyvinyl alcohol, water, and glacial acetic acid. The effective components of the herbal medicine are extracted by decoction, concentrated, and freeze-dried to obtain a freeze-dried powder. This powder is then mixed with a chitosan aqueous solution and cross-linked using a liquid nitrogen cyclic freezing method to form the hydrogel. This invention closely addresses the core pathogenesis of diabetic foot ulcers—"blood stasis, dampness, and heat (toxin)"—allowing the various herbs to synergistically exert their effects of clearing heat and detoxifying, promoting blood circulation and removing blood stasis, drying dampness and astringing sores, and nourishing blood and promoting tissue regeneration. The chitosan matrix endows the hydrogel with good biocompatibility, antibacterial properties, and sustained-release drug properties, which can improve the microenvironment of the ulcer wound, inhibit inflammatory responses, and promote granulation tissue growth, effectively promoting the healing of skin sores such as diabetic foot ulcers, and has broad application prospects.
Owner:SHANDONG UNIV OF TRADITIONAL CHINESE MEDICINE

New application of beta-anhydroicaritin

The invention belongs to the technical field of medicines, and particularly discloses novel application of beta-anhydroicaritin. The preparation method comprises the following steps: constructing an MC38 colorectal cancer cell line of an expression mode antigen OVA, expressing an OVA257-264 mode peptide fragment under the molecular presentation action of a main histocompatibility compound H2b, separating OT-1T cells for specifically recognizing the OVA257-264 mode peptide fragment, inducing and activating, co-culturing the OT-1T cells, MC38-OVA and different traditional Chinese medicine monomeric compounds, and screening the cells to obtain the colorectal cancer cell line. The beta-anhydroicaritin is screened from 1280 traditional Chinese medicine monomer compounds through a high content screening technology. In-vivo and in-vitro experiment results show that the beta-anhydroicaritin can remarkably promote T cell activation, release cell factors such as IFN-gamma, TNF-alpha and Granzyme B, promote killing of tumor cells and inhibit tumor growth, and can be used for preparing the medicine for preventing and / or treating tumors.
Owner:ZHENGZHOU UNIV

Preparation for treating primary biliary cholangitis and preparation method thereof

ActiveCN117883539BImprove hypochondriac painStrong targetingAntipyreticDigestive systemBile JuiceCorn silk
The invention discloses a preparation for treating primary biliary cholangitis, aiming to solve the problems of long treatment course and high cost of western medicine for treating primary biliary cholangitis. The preparation comprises the following raw materials in parts by weight: 50-70 parts of corn silk, 20-40 parts of wax gourd peel, 20-40 parts of coix seeds, 10-20 parts of perilla, 3-9 parts of amomum, 20-40 parts of desmodium, 20-40 parts of sea sand, 10-20 parts of turmeric, 10-20 parts of knotweed, 10-20 parts of chicken gizzard lining, and 1-5 parts of Uncaria rhynchophylla. This prescription has no obvious toxic side effects, and is easily available, simple to make, easy to use, inexpensive, and highly practical. The whole prescription can clear the liver and gallbladder, strengthen the spleen and eliminate dampness, and can effectively improve the bilirubin, alkaline phosphatase, glutamyl transpeptidase, alanine aminotransferase, aspartate aminotransferase, total cholesterol, triglycerides and other indicators of patients with primary biliary cholangitis, with an overall effective rate of 93.3%.
Owner:HENAN UNIV OF CHINESE MEDICINE

A thiophene-phenothiazine compound and its synthesis method and application in the preparation of phototherapy drugs

ActiveCN116444542BExcellent photodynamic activitystrong wavelength absorptionOrganic active ingredientsOrganic chemistryPhoto stabilityPharmaceutical medicine
The present invention belongs to the field of biomedical technology, and particularly relates to a thiophene-phenothiazine compound and a synthesis method thereof and an application in the preparation of phototherapy drugs. The present invention provides a thiophene-phenothiazine compound or a pharmaceutically acceptable salt thereof, in which the thiophene structure is successfully fused to the phenothiazine skeleton, providing a new molecular scaffold; the special structure exhibits excellent photodynamic activity, has strong wavelength absorption and good light stability in the near-infrared region, and can efficiently generate ROS under red light, so it can be used as a photosensitizer. The thiophene-phenothiazine compound of the present invention has strong phototoxicity and a high phototherapy index, exhibits strong photodynamic anti-tumor activity, and has no obvious toxic side effects, and is expected to become a new generation of new photosensitizers that can be applied to clinical practice, and is applied to the preparation of phototherapy drugs or their lead compounds.
Owner:GUANGZHOU MEDICAL UNIV

Application of combination of CB-839 and atorvastatin calcium in preparation of medicine for treating heart failure

The invention discloses application of combination of CB-839 and atorvastatin calcium in preparation of a medicine for treating heart failure, and belongs to the technical field of medicines. The invention finds that the CB-839 has obvious curative effects of relieving clinical symptoms, improving heart functions and improving physical strength in the treatment of heart failure, which indicates that the CB-839 has the functions of relieving cardiomyopathy injury by reducing inflammatory cell infiltration, myocardial fibrosis, myocardial tissue cell apoptosis and the like. Compared with other glutaminase inhibitors, the CB-839 has the most obvious effect. The invention also finds that the CB-839 and atorvastatin calcium (At-Ca) which is a clinical first-line therapeutic drug for heart failure are combined, the curative effect of the CB-839 and atorvastatin calcium (At-Ca) combined drug is about 3 times that of a single drug and is far better than that of the single drug, the CB-839 and the At-Ca combined drug have no obvious toxic or side effect, and the optimal ratio of the CB-839 to the At-Ca combined drug is 33: 1. In conclusion, the CB-839 has the application of preparing the medicine for treating the heart failure.
Owner:朱耀西

Traditional Chinese medicine composition for treating primary sicca syndrome complicated with interstitial lung disease and application thereof

The invention provides a traditional Chinese medicine composition for treating primary sicca syndrome complicated with interstitial lung disease and application of the traditional Chinese medicine composition, and relates to the technical field of traditional Chinese medicines. The traditional Chinese medicine composition is prepared from the following traditional Chinese medicine raw materials in parts by weight: 10-15g of radix glehniae, 10-15g of radix ophiopogonis, 15-30g of radix pseudostellariae, 10-20g of curcuma zedoary, 6-12g of roasted stiff silkworm and 15-30g of wild buckwheat rhizome. The traditional Chinese medicine composition can safely and effectively improve the respiratory function, dry mouth, dry eye and other symptoms of pSS-ILD patients, improve the life quality of the patients and delay the disease progression, has no obvious side effect, and is simple in formula and low in cost.
Owner:NANJING UNIV OF TRADITIONAL CHINESE MEDICINE

Compound polysaccharide for regulating and controlling immune balance of Th1 / Th2 as well as preparation method and application of compound polysaccharide

The invention discloses a compound polysaccharide for regulating Th1 / Th2 immune balance as well as a preparation method and application of the compound polysaccharide. The compound polysaccharide is prepared from medicinal and edible plants and edible mushrooms as raw materials, and the raw materials comprise agaricus blazei murill, seaweed, liquorice, rhizoma polygonati and honeysuckle. Compared with the current medicine for treating ovalbumin induced immune stress, the compound polysaccharide disclosed by the invention can be eaten for a long time and has no obvious toxic or side effect. Moreover, the compound polysaccharide disclosed by the invention is subjected to co-extraction to obtain a molecular weight segment with an effect on immunoregulation, and compared with the immunoregulation effect of single polysaccharide, the compound polysaccharide disclosed by the invention has an obvious synergistic benefit. The compound polysaccharide provided by the invention can regulate Th1 / Th2 immune balance, prevent and / or inhibit immune stress reaction caused by ovalbumin, and provide effective support for wide application of ovalbumin.
Owner:INFINITUS (CHINA) CO LTD